文献速递皮肤肿瘤

光动力疗法治疗皮肤鳞状细胞癌的现状与未来展望

Present and future perspectives of photodynamic therapy for cutaneous squamous cell carcinoma.
PubMed 文献 · J Am Acad Dermatol · 2018-10-28

皮肤鳞状细胞癌(SCC)是第二常见皮肤癌,手术仍是主要治疗,但部分患者不适合手术,关键部位病变需保留组织的非手术方法。光动力疗法(PDT)作为非侵入或微创治疗已被广泛研究,在安全性、疗效和美容效果方面显示良好前景,但人体研究在样本量和肿瘤浸润深度方面有限,良好结果主要见于微浸润SCC(限于真皮乳头层)的病例报告。本文讨论PDT治疗皮肤SCC的疗效与安全性研究、作用机制、增强剂及联合辅助治疗。

要点

  • 手术仍是皮肤SCC的主要治疗,但部分患者不适合手术,关键部位病变需非手术方法以保留组织。
  • PDT作为非侵入或微创治疗已被广泛研究,在安全性、疗效和美容效果方面显示良好前景。
  • 人体研究在样本量和肿瘤浸润深度方面有限,良好结果主要见于微浸润SCC(限于真皮乳头层)的病例报告。

核心结论

  • PDT作为非侵入或微创治疗皮肤SCC已被广泛研究,在安全性、疗效和美容效果方面显示良好前景,但人体研究在样本量和肿瘤浸润深度方面有限。

主要发现

  • 良好结果主要见于微浸润SCC(限于真皮乳头层)的病例报告。
  • 疗效不足的原因在于局部应用的光敏剂对角化肿瘤表面穿透不足。

局限性

  • 人体研究在样本量和肿瘤浸润深度方面有限。
  • 良好结果主要见于微浸润SCC(限于真皮乳头层)的病例报告。
  • 疗效不足的原因在于局部应用的光敏剂对角化肿瘤表面穿透不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cutaneous squamous cell carcinoma (SCC) is the second most common skin cancer. Surgery remains the main stay of treatment, but some patients are not eligible for surgery and, more importantly, lesions at critical sites need nonsurgical approaches for tissue preservation. In this context, photodynamic therapy (PDT) has been extensively studied as noninvasive or minimally invasive treatment, and studies have shown promising results in terms of safety, efficacy, and cosmetic outcome. Also, studies have proposed different mechanism for its efficacy. However, human studies demonstrating its efficacy are limited in terms of sample size and tumor depth of invasion. Good results are mainly seen in case reports of microinvasive SCC, which is defined as SCC limited to papillary dermis. This inadequacy is due to inadequate penetration of topically applied photosensitizers through keratinized tumor surfaces. To overcome these hurdles, pretreatment with lasers or microneedles and encapsulation of photosensitizers into nanoparticles have been tried. Hence, the present article will discuss studies that have demonstrated the efficacy and safety of PDT for cutaneous SCC, studies that have postulated the mechanism of action of PDT, agents that have been used as PDT enhancers, and finally, the recent use of adjuvant therapy in combination with PDT.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Keyal U, Bhatta AK, Zhang G, et al. Present and future perspectives of photodynamic therapy for cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2018. PMID: 30393093. doi:10.1016/j.jaad.2018.10.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。